
olmesartan medoxomil
Pharmaranks rates Olmesartan Medoxomil 3.4/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Olmesartan Medoxomil is an angiotensin 2 receptor blocker used to treat Diabetic Nephropathies, Heart Failure, Hypertension, Left Ventricular Dysfunction.
Angiotensin 2 Receptor Blocker · by Sandoz
Generic of Benicar
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Olmesartan Medoxomil
- Drug class
- Angiotensin 2 Receptor Blocker
- Form
- Tablet
- Strength
- Olmesartan Medoxomil 20MG · Olmesartan Medoxomil 40MG · Olmesartan Medoxomil 5MG
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- May treat
- diabetic nephropathies, heart failure, hypertension
- Manufacturer
- Sandoz
- What the pharmacy pays
- ~$2.24 for 30 — not your price
- FDA application
- ANDA090237
- Availability
- Discontinued (per FDA)
Foods & drinks to be careful with
Well-established interactions for this medicine’s drug class, summarized from public health authorities. General information, not medical advice — always confirm with your pharmacist or the label.
Potassium-rich foods & salt substitutes
Watch out for: salt substitutes containing potassium, and large amounts of potassium-rich foods or supplements.
These medicines can raise blood potassium. Adding a lot of extra potassium can push it too high (hyperkalemia), which can affect the heart.
What to do: Don't use potassium-based salt substitutes unless your clinician approves, and ask before taking potassium supplements. Your clinician may check your potassium level with blood tests.
Source: Lisinopril (an ACE inhibitor) — MedlinePlus (U.S. National Library of Medicine) · Spironolactone (a potassium-sparing diuretic) — MedlinePlus (U.S. National Library of Medicine)
Drug class
How this class works, per Angiotensin II Receptor Blockers (ARB) - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Olmesartan Medoxomil ranks — best-rated angiotensin 2 receptor blocker for:
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Olmesartan Medoxomil treat?
- Olmesartan Medoxomil (Olmesartan Medoxomil) may be used to treat diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Olmesartan Medoxomil work?
- Olmesartan Medoxomil is a angiotensin 2 receptor blocker. Angiotensin II receptor blockers (ARBs) block the AT1 receptor that the hormone angiotensin II uses to tighten blood vessels and make the body hold onto salt and water. With that receptor blocked, vessels relax and widen, so blood pressure falls.
- How is Olmesartan Medoxomil rated?
- pharmaranks gives Olmesartan Medoxomil a composite score of 3.4 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Olmesartan Medoxomil cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $2.24 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Olmesartan Medoxomil?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Olmesartan Medoxomil. To pay less, Olmesartan Medoxomil is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Olmesartan Medoxomil?
- Olmesartan Medoxomil is marketed by Sandoz. You can see Sandoz's full profile, rating, and other products on pharmaranks.
- Is Olmesartan Medoxomil a brand-name or generic drug?
- Olmesartan Medoxomil is a generic medication; its active ingredient is Olmesartan Medoxomil. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Olmesartan Medoxomil available over the counter?
- No. Olmesartan Medoxomil is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Olmesartan Medoxomil come in?
- Olmesartan Medoxomil is currently marketed as tablet, per the FDA's National Drug Code Directory.
- What class of drug is Olmesartan Medoxomil?
- Olmesartan Medoxomil is classified as angiotensin 2 receptor blocker, per the FDA's Established Pharmacologic Class.
- Is Olmesartan Medoxomil FDA-registered?
- Olmesartan Medoxomil is on record with the U.S. FDA under application number ANDA090237. You can verify this on its official FDA label.
- Has Olmesartan Medoxomil been recalled by the FDA?
- Olmesartan Medoxomil has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Olmesartan Medoxomil safe?
- There's no single safe-or-not verdict. pharmaranks gives Olmesartan Medoxomil a recall-safety score of 68/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
micardis
Telmisartan
atacand
Candesartan Cilexetil
avapro
Irbesartan
benicar
Olmesartan Medoxomil
valsartan
Valsartan
irbesartan
Irbesartan
Compare Olmesartan Medoxomil head-to-head
More angiotensin 2 receptor blocker drugs
Guides for this medication
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
olmesartan medoxomil
68/100